PMID- 8300859 OWN - NLM STAT- MEDLINE DCOM- 19940308 LR - 20190825 IS - 0165-5728 (Print) IS - 0165-5728 (Linking) VI - 50 IP - 1 DP - 1994 Feb TI - Beta-endorphin modulates calcium channel activity in human neutrophils. PG - 77-83 AB - 10(-6) M n-formyl-methionyl-leucyl-phenylalanine (FMLP) stimulated Ca2+ flux in human neutrophils is characterized by a profile composed of two peaks of different amplitude and breadth. beta-Endorphin inhibited the magnitude and modulated the kinetics of the second peak in a manner which was dose-dependent and could reflect either negative cooperativity or heterogeneity of binding sites. The second peak arises from calcium channel activity since in the presence of nifedipine or EGTA it was not evident while the first peak was reduced about 24%. Similarly, at 15 degrees C, where we were unable to detect any channel activity, the first peak was diminished by 35% and beta-endorphin had no detectable effect on this peak. These results led us to conclude that the first peak is chiefly composed of Ca2+ recruited from cytosolic stores which are relatively insensitive to the above treatments and a smaller fraction of calcium originating in calcium channel activity. Hence, we reason that beta-endorphin modulates only the calcium ion flux arising from calcium channel function. FAU - Mazorow, D L AU - Mazorow DL AD - New Ideas Co., Rockville, MD 20852. FAU - Simpkins, C O AU - Simpkins CO FAU - Millar, D B AU - Millar DB LA - eng PT - Journal Article PL - Netherlands TA - J Neuroimmunol JT - Journal of neuroimmunology JID - 8109498 RN - 0 (Calcium Channels) RN - 526U7A2651 (Egtazic Acid) RN - 60617-12-1 (beta-Endorphin) RN - I9ZF7L6G2L (Nifedipine) RN - SY7Q814VUP (Calcium) SB - IM MH - Calcium/metabolism MH - Calcium Channels/*drug effects/physiology MH - Cytosol/metabolism MH - Egtazic Acid/pharmacology MH - Humans MH - Neutrophils/*drug effects/metabolism MH - Nifedipine/pharmacology MH - Temperature MH - beta-Endorphin/*pharmacology EDAT- 1994/02/01 00:00 MHDA- 2000/06/01 09:00 CRDT- 1994/02/01 00:00 PHST- 1994/02/01 00:00 [pubmed] PHST- 2000/06/01 09:00 [medline] PHST- 1994/02/01 00:00 [entrez] AID - 0165-5728(94)90217-8 [pii] AID - 10.1016/0165-5728(94)90217-8 [doi] PST - ppublish SO - J Neuroimmunol. 1994 Feb;50(1):77-83. doi: 10.1016/0165-5728(94)90217-8.